Old Mission Capital’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Old Mission Capital’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,286	Closed	-$2K	–	1486
2022 Q2	$2K	Buy	14,286 +635	+5%	+$105	﹤0.01%	1328
2022 Q1	$6K	Buy	13,651 +1,014	+8%	+$331	﹤0.01%	1267
2021 Q4	$5K	Buy	+12,637	New	+$8.67K	﹤0.01%	1004

Other funds holding APGNW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Old Mission Capital's APGNW Position: Q3 2022 in Review

Old Mission Capital sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2022, closing a stake of 14,286 shares — an estimated $2K sold.

Old Mission Capital first reported a position in APGNW in Q4 2021 and held it in 3 quarters. The position peaked at $6K in Q1 2022. 16 funds tracked by Wall St. Rank hold APGNW as of Q3 2022.

Old Mission Capital reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
Old Mission Capital sold 14,286 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2022, an estimated $2K.
Old Mission Capital first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q4 2021 and held it in 3 quarters.
Old Mission Capital's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $6K in Q1 2022.
16 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2022.

Based on Old Mission Capital's 13F filing for Q3 2022, filed 14 Nov 2022.